注射用血塞通对不稳定型心绞痛疗效及血清C反应蛋白的影响  

Effect of Xuesaitong Injectioin on Unstable Angina Pectoris and Serum C-reactive Protein

作　　者：高凤敏[1] 杨骄霞[1] 李凤翔[1] 

机构地区：[1]牡丹江医学院红旗医院

出　　处：《中西医结合心脑血管病杂志》2011年第9期1054-1055,共2页Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

摘　　要：目的观察注射用血塞通治疗不稳定型心绞痛的临床疗效及对血清C反应蛋白(CRP)的影响。方法将不稳定型心绞痛患者40例随机分为两组。对照组20例予硝酸酯类、美托洛尔、阿司匹林、阿托伐他汀等治疗。治疗组20例在对照组治疗基础上加用注射用血塞通400mg,加入5%葡萄糖注射液250mL中静脉输注,每日1次,2周1个疗程。结果两组症状比较,治疗组总效率90%,对照组总有效率65%。两组心电图(ECG)疗效比较,治疗组总效率90%,对照组总有效率60%,差异有统计学意义(P<0.05)。两组CRP治疗后与治疗前相比,组内及组间比较差异均有统计学意义(P<0.05)。结论常规疗法联合注射用血塞通对不稳定型心绞痛具有良好的疗效。Objective To observe the effect of Xuesaitong injectioin on unstable angina pectoris and serum C-reactive protein（CRP）.Methods Forty patients（pts） with unstable angina patients were randomly divided into two groups：Control group（n=20） treated with nitrates,metoprolol,aspirin,atorvastatin,and treatment group（n=20） treated with routine therapy and Xuesaitong injectioin for 2 weeks.Results The total symptoms efficiency was 90% in treatment group,and 65% in control group.The total electrocardiogram（ECG） efficacy rate was 90% in treatment group,and 60% in control group（P0.05）.The level of serum CRP in treatment group was lower than that in control group（P0.05）.Conclusion Routine therapy combined with Xuesaitong injection was effective for treatment of unstable angina pectoris.

关 键 词：不稳定型心绞痛 注射用血塞通 C反应蛋白 

分 类 号：R541.4[医药卫生—心血管疾病] R289.5[医药卫生—内科学]